Stocks › Drug Manufacturers - General › AZN

AstraZeneca AZN

US equityMarket cap rank #56Drug Manufacturers - General Infectious Disease

$165.79

+$2.46 (+1.51%)

Market open · Sep 24, 1:10 pm ET

After hours $164.57 +0.76%

Open$162.93

Prev close$163.33

Day range$162.92 – $166.25

Volume1.92M

Market cap$257.12B

P/E (TTM)24.8

Dividend yield1.91%

A Quick Look at Today's Ratings for AstraZeneca(AZN.US), With a Forecast Between $155.74 to $223.46 Market news · 9 Sep 2026
Citi Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $240.5 Market news · 7 Sep 2026
AstraZeneca Wins U.S. Approval for Etcamah Combo to Tackle Endocrine‐Resistant Breast Cancer TipRanks · 7 Sep 2026
Barclays Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $222.94 Market news · 7 Sep 2026
Jefferies Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $236.45 Market news · 7 Sep 2026
AstraZeneca Scores Minor Positive With U.S. Approval for Breast-Cancer Drug -- Market Talk WSJ · 7 Sep 2026
Berenberg Bank Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $215.74 Market news · 3 Sep 2026
Deutsche Bank Maintains AstraZeneca(AZN.US) With Sell Rating, Cuts Target Price to $155.06 Market news · 2 Sep 2026
Berenberg Bank Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $216.95 Market news · 10 Sep 2026
RBC Capital Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $196.61 Market news · 10 Sep 2026
HSBC Maintains AstraZeneca(AZN.US) With Hold Rating, Raises Target Price to $188.75 Market news · 10 Sep 2026
Goldman Sachs Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $221.02 Market news · 10 Sep 2026
J.P. Morgan Maintains AstraZeneca(AZN.US) With Buy Rating, Cuts Target Price to $215.74 Market news · 1 Sep 2026
TD Cowen Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $240 Market news · 1 Sep 2026
J.P. Morgan Reaffirms Their Buy Rating on AstraZeneca (AZN) TipRanks · 1 Sep 2026